Vesper Medical is shaping the future of treating deep venous disease through the creation of a next-generation, modular, and uniquely engineered venous stent portfolio that addresses the multiple anatomical challenges presented by the iliac and femoral veins and provides the ability to customize therapy.
- Year invested 2016
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Historic
- Associated Team
- Company Status Acquired (by Royal Philips (NYSE: PHG, AEX: PHIA))